The Patent Finder

Terms ending in 2039

Seegene, Inc.

Every in-force patent on Seegene, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,401,546Detection of Target Nucleic Acid Sequences by Pto Cleavage and Extension-Dependent Extension Assay
In force
 · High confidence
Seegene, Inc.In forceHigh confidence
US 11,448,658Method and Device for Controlling Detection-Composition Preparation Instrument
In force
 · High confidence
Seegene, Inc.In forceHigh confidence
US 11,485,998Signal Extraction for a Target Nucleic Acid Sequence
In force
 · High confidence
Seegene, Inc.In forceHigh confidence
US 12,018,318Method and Device for Analyzing Target Analyte in Sample
In force
 · High confidence
Seegene, Inc.In forceHigh confidence
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited